OncoGenex prices offering

OncoGenex Pharmaceuticals (OGXI +2.6%) offers 5,559,866 Series A units and 1,340,538 Series B units for public sale. Each Series A unit consist of one share of common stock plus one warrant to purchase 1/2 share of common at $4.00 per share for a five-year term. The warrants are immediately exercisable.

The Series B units will be offered and sold to those Series A buyers whose purchases would increase their stake in the company to greater than 9.99%. Each Series B unit consists of one pre-funded warrant to purchase one share of common stock and one warrant to purchase 1/2 share of common stock at $4.00 for a five-year term.

Gross proceeds will be ~$24M.


Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs